Literature DB >> 16971027

Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag.

Jian-Tai Qiu1, Ting-Chang Chang, Cheng-Tao Lin, Yi-Ming Chen, Frank Q Li, Yung-Kuei Soong, Chyong-Huey Lai.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a potent immunomodulatory cytokine. Here we generated a novel codon-optimized murine GM-CSF gene as an adjuvant. The codon-optimized GM-CSF gene significantly increased protein expression levels in all cells tested. Although injection of the wild-type GM-CSF plasmids adjuvanted HIV-1 Gag DNA vaccine induced detectable immune responses, co-administration of plasmids encoding the codon-optimized GM-CSF sequence with the DNA vaccine resulted in a strong antibody and CTL responses and a protective immune response against infection with recombinant vaccinia virus expressing HIV-1 Gag. This novel codon-optimized GM-CSF gene offers a practical molecular strategy for potentiating immune responses to vaccines as well as other immunotherapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971027     DOI: 10.1016/j.vaccine.2006.07.034

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  A fusion-protein approach enabling mammalian cell production of tumor targeting protein domains for therapeutic development.

Authors:  Jia Hu; Xiang Chen; Xuhua Zhang; Xiaopeng Yuan; Mingjuan Yang; Hui Dai; Wei Yang; Qinghua Zhou; Weihong Wen; Qirui Wang; Weijun Qin; Aizhi Zhao
Journal:  Protein Sci       Date:  2018-04-14       Impact factor: 6.725

2.  Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial.

Authors:  Paul Spearman; Spyros Kalams; Marnie Elizaga; Barbara Metch; Ya-Lin Chiu; Mary Allen; Kent J Weinhold; Guido Ferrari; Scott D Parker; M Juliana McElrath; Sharon E Frey; Jonathan D Fuchs; Michael C Keefer; Michael D Lubeck; Michael Egan; Ralph Braun; John H Eldridge; Barton F Haynes; Lawrence Corey
Journal:  Vaccine       Date:  2008-11-07       Impact factor: 3.641

Review 3.  Novel GM-CSF-based vaccines: One small step in GM-CSF gene optimization, one giant leap for human vaccines.

Authors:  Ting-Wei Yu; Ho-Yen Chueh; Ching-Chou Tsai; Cheng-Tao Lin; Jiantai Timothy Qiu
Journal:  Hum Vaccin Immunother       Date:  2016-08-25       Impact factor: 3.452

Review 4.  Modulation of HIV-1 immunity by adjuvants.

Authors:  M Anthony Moody
Journal:  Curr Opin HIV AIDS       Date:  2014-05       Impact factor: 4.283

5.  Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines.

Authors:  Rong Xu; Shakuntala Megati; Vidia Roopchand; Amara Luckay; Amjed Masood; Dorys Garcia-Hand; Margherita Rosati; David B Weiner; Barbara K Felber; George N Pavlakis; Maninder K Sidhu; John H Eldridge; Michael A Egan
Journal:  Vaccine       Date:  2008-07-25       Impact factor: 4.169

6.  Immune response to dna vaccine expressing transferrin binding protein a gene of Pasteurella multocida.

Authors:  Satparkash Singh; Vijendra Pal Singh; Pawanjit Singh Cheema; Maninder Sandey; Rajeev Ranjan; Santosh Kumar Gupta; Bhaskar Sharma
Journal:  Braz J Microbiol       Date:  2011-06-01       Impact factor: 2.476

7.  Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses.

Authors:  Vinicius Canato Santana; Rafael Ribeiro Almeida; Susan Pereira Ribeiro; Luís Carlos de Souza Ferreira; Jorge Kalil; Daniela Santoro Rosa; Edecio Cunha-Neto
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-11-24       Impact factor: 2.743

8.  Albumin fusion with granulocyte-macrophage colony-stimulating factor acts as an immunotherapy against chronic tuberculosis.

Authors:  Yu-Min Chuang; Liangmei He; Michael L Pinn; Ya-Chea Tsai; Max A Cheng; Emily Farmer; Petros C Karakousis; Chien-Fu Hung
Journal:  Cell Mol Immunol       Date:  2020-05-07       Impact factor: 11.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.